A Feasibility Trial of Tazemetostat Plus CAR T Cell Therapy in B-cell Lymphomas

NCT05934838 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Follicular Lymphoma
B-Cell Lymphoma
Mantle Cell Lymphoma
Diffuse Large B Cell Lymphoma

Interventions

DRUG: Tazemetostat Pill

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]
[object Object]
[object Object]